心房颤动与HP感染的相关性研究——Meta分析
Association between Atrial Fibrillation and Helicobacter pylori Infection—A Meta-Analysis
DOI: 10.12677/acm.2025.1551374, PDF,   
作者: 苏倚婷, 陈冬冬:暨南大学附属第一医院心血管内科,广东 广州
关键词: 心房颤动幽门螺旋杆菌感染Meta分析Atrial Fibrillation Helicobacter pylori Infection Meta-Analysis
摘要: 目的:Meta分析系统评价心房颤动患者与幽门螺旋杆菌(HP)感染的相关性。方法:计算机检索中国知网(CNKI)、维普(VIP)、万方数据知识服务平台、PubMed、Embase、Cochrane等,检索时间限定为1999年1月~2024年1月,对纳入的病例对照研究进行数据提取及NOS量表评价,分析房颤患者与幽门螺旋杆菌感染是否存在相关性。结果:共检索到中英文文献177篇,12篇病例对照研究被纳入,3755例患者被纳入研究。纳入的12篇文献存在异质性(I2 = 66%, P = 0.0006),因此选择随机效应模型合并效应量,得到OR = 1.66 (95%CI: 1.21~2.28, Z = 3.16, P = 0.002),提示与非房颤组相比,房颤患者合并幽门螺旋杆菌感染的可能性更高。敏感性分析未考察出异质的来源。亚组分析提示亚洲、非洲地域的房颤患者合并HP感染可能性更高,而在欧美澳地区房颤与HP未见存在相关性。Begg检验提示发表偏倚较小。结论:在亚洲、非洲地区,HP感染会增加房颤的发生风险。
Abstract: Objective: This meta-analysis systematically evaluates the correlation between atrial fibrillation (AF) and Helicobacter pylori (HP) infection. Methods: Computerized searches were conducted in databases including CNKI, VIP, Wanfang, PubMed, Embase, and Cochrane, with the search period limited from January 1999 to January 2024. Data were extracted from included case-control studies, and the Newcastle-Ottawa Scale (NOS) was used for quality assessment. The analysis aimed to determine whether an association exists between AF and HP infection. Results: A total of 177 Chinese and English articles were retrieved, with 12 case-control studies (involving 3,755 patients) included in the final analysis. The included studies exhibited heterogeneity (I² = 66%, P = 0.0006), so a random-effects model was used to pool effect sizes. The combined odds ratio (OR) was 1.66 (95%CI: 1.21~2.28, Z = 3.16, P = 0.002), indicating that AF patients had a significantly higher likelihood of HP infection compared to non-AF controls. Sensitivity analysis did not identify the source of heterogeneity. Subgroup analysis suggested that AF patients in Asia and Africa had a higher probability of HP co-infection, whereas no significant correlation was found in Europe, America, or Australia. Begg’s test indicated minimal publication bias. Conclusion: In Asia and Africa, HP infection may increase the risk of atrial fibrillation.
文章引用:苏倚婷, 陈冬冬. 心房颤动与HP感染的相关性研究——Meta分析[J]. 临床医学进展, 2025, 15(5): 324-334. https://doi.org/10.12677/acm.2025.1551374

参考文献

[1] 中华医学会心血管病学分会, 中国生物医学工程学会心律分会. 心房颤动诊断和治疗中国指南[J]. 中华心血管病杂志, 2023, 51(6): 572-618.
[2] Manolis, A.A., Manolis, T.A. and Manolis, A.S. (2025) Current Strategies for Atrial Fibrillation Prevention and Management: Taming the Commonest Cardiac Arrhythmia. Current Vascular Pharmacology, 23, 31-44. [Google Scholar] [CrossRef] [PubMed]
[3] 丁宇, 王海军, 尹新华, 等. 高龄心房颤动患者抗凝治疗中国专家共识(2024) [J]. 中华老年心脑血管病杂志, 2024, 26(10): 1113-1124.
[4] Wei, Y., Zhou, G., Wu, X., Lu, X., Wang, X., Wang, B., et al. (2023) Latest Incidence and Electrocardiographic Predictors of Atrial Fibrillation: A Prospective Study from China. Chinese Medical Journal, 136, 313-321. [Google Scholar] [CrossRef] [PubMed]
[5] Randhawa, S., Das, S. and Aronow, W.S. (2023) Risk Factors Modification in Atrial Fibrillation: A Brief Review. Expert Review of Cardiovascular Therapy, 22, 7-12. [Google Scholar] [CrossRef] [PubMed]
[6] Heijman, J., Voigt, N., Nattel, S. and Dobrev, D. (2014) Cellular and Molecular Electrophysiology of Atrial Fibrillation Initiation, Maintenance, and Progression. Circulation Research, 114, 1483-1499. [Google Scholar] [CrossRef] [PubMed]
[7] Montenero, A.S. (2005) Helicobacter pylori and Atrial Fibrillation: A Possible Pathogenic Link. Heart, 91, 960-961. [Google Scholar] [CrossRef] [PubMed]
[8] Bunch, T.J., Day, J.D., Anderson, J.L., Horne, B.D., Muhlestein, J.B., Crandall, B.G., et al. (2008) Frequency of Helicobacter pylori Seropositivity and C-Reactive Protein Increase in Atrial Fibrillation in Patients Undergoing Coronary Angiography. The American Journal of Cardiology, 101, 848-851. [Google Scholar] [CrossRef] [PubMed]
[9] Wang, D., Chen, W., Yang, S., Wang, J., Li, Q., Fu, Q., et al. (2015) Helicobacter pylori Infection in Chinese Patients with Atrial Fibrillation. Clinical Interventions in Aging, 10, 813-819. [Google Scholar] [CrossRef] [PubMed]
[10] Monica, L., Giovanni, F., Valeria, A., Egle, C., Sutera, L., Enrico, A., et al. (2009) Helicobacter pylori and Atrial Fibrillation: Absence of Correlations. Journal of Cardiovascular Medicine, 10, 4-5. [Google Scholar] [CrossRef] [PubMed]
[11] Schimke, K., Chubb, S.A.P., Davis, W.A. and Davis, T.M.E. (2010) Helicobacter pylori Cytotoxin-Associated Gene-A Antibodies Do Not Predict Complications or Death in Type 2 Diabetes: The Fremantle Diabetes Study. Atherosclerosis, 212, 321-326. [Google Scholar] [CrossRef] [PubMed]
[12] Yan, J., She, Q., Zhang, Y.F., Cui, C. and Zhang, G.X. (2016) The Association between Arrhythmia and Helicobacter pylori Infection: A Meta-Analysis of Case-Control Studies. International Journal of Environmental Research and Public Health, 13, Article 1139.
https://pubmed.ncbi.nlm.nih.gov/27854353/
[13] Tetta, C., Moula, A.I., Matteucci, F., Parise, O., Maesen, B., Johnson, D., et al. (2019) Association between Atrial Fibrillation and Helicobacter pylori. Clinical Research in Cardiology, 108, 730-740. [Google Scholar] [CrossRef] [PubMed]
[14] Badran, H.M. and Mahfouz, M.E. (2007) Cytotoxin-Associated Gene-A Bearing Strains of Helicobacter pylori and Atrial Fibrillation Due to Ischemic Origin: Is There a Link? European Journal of Cardiovascular Prevention & Rehabilitation, 14, 518-520. [Google Scholar] [CrossRef] [PubMed]
[15] P. Platonov,, R. Ekesbo,, A. Hansson,, E. Andsberg,, C.J. Meurling,, I. Nilsson,, et al. (2008) Permanent Atrial Fibrillation in Patients without Structural Heart Disease Is Not Associated with Signs of Infection by Chlamydia pneumoniae and Helicobacter pylori. Acta Cardiologica, 63, 479-484. [Google Scholar] [CrossRef] [PubMed]
[16] Ki, M., Shin, D., Park, J., Hong, K., Hong, I., Park, J., et al. (2010) Frequency of Vacuolating Cytotoxin a (VacA)-Positive Helicobacter pylori Seropositivity and TGF-β1 Decrease in Atrial Fibrillation. International Journal of Cardiology, 145, 345-346. [Google Scholar] [CrossRef] [PubMed]
[17] Franceschi, F., Brisinda, D., Buccelletti, F., Ruggieri, M.P., Gasbarrini, A., Sorbo, A., et al. (2011) Prevalence of Virulent Helicobacter pylori Strains in Patients Affected by Idiopathic Dysrhythmias. Internal and Emergency Medicine, 8, 333-337. [Google Scholar] [CrossRef] [PubMed]
[18] 王馨. 房颤与超敏c反应蛋白及幽门螺旋杆菌的相关性研究[D]: [硕士学位论文]. 遵义: 遵义医学院, 2019.
[19] 王龙, 周纬, 王学文, 等. 心房颤动患者幽门螺旋杆菌感染的发生率及相关因素分析[J]. 中国心脏起搏与心电生理杂志, 2016, 30(6): 497-499.
[20] 白芳, 李学文. C反应蛋白及幽门螺旋杆菌与房颤的相关性研究[J]. 中西医结合心脑血管病杂志, 2014, 12(11): 1330-1331.
[21] 张晓宇, 单其俊, 邹建刚. 心房颤动与炎症及慢性幽门螺旋杆菌感染相关性研究[J]. 中国心脏起搏与心电生理杂志, 2007, 21(3): 219-221.
[22] Li, M., Zeng, X., Wu, F., Chu, Y., Wei, W., Fan, M., et al. (2023) Build a Bridge between ECG and EEG Signals for Atrial Fibrillation Diagnosis Using AI Methods. Computers in Biology and Medicine, 166, Article ID: 107429. [Google Scholar] [CrossRef] [PubMed]
[23] Xie, J., Stavrakis, S. and Yao, B. (2024) Automated Identification of Atrial Fibrillation from Single-Lead ECGs Using Multi-Branching Resnet. Frontiers in Physiology, 15, Article 1362185. [Google Scholar] [CrossRef] [PubMed]
[24] Grzeczka, A., Graczyk, S. and Kordowitzki, P. (2023) DNA Methylation and Telomeres—Their Impact on the Occurrence of Atrial Fibrillation during Cardiac Aging. International Journal of Molecular Sciences, 24, Article 15699. [Google Scholar] [CrossRef] [PubMed]
[25] Newman, J.D., O’Meara, E., Böhm, M., Savarese, G., Kelly, P.R., Vardeny, O., et al. (2024) Implications of Atrial Fibrillation for Guideline-Directed Therapy in Patients with Heart Failure: JACC State-of-the-Art Review. Journal of the American College of Cardiology, 83, 932-950. [Google Scholar] [CrossRef] [PubMed]
[26] Sagris, M., Vardas, E.P., Theofilis, P., Antonopoulos, A.S., Oikonomou, E. and Tousoulis, D. (2021) Atrial Fibrillation: Pathogenesis, Predisposing Factors, and Genetics. International Journal of Molecular Sciences, 23, Article 6. [Google Scholar] [CrossRef] [PubMed]
[27] Shakir, S.M., Shakir, F.A. and Couturier, M.R. (2023) Updates to the Diagnosis and Clinical Management of Helicobacter pylori Infections. Clinical Chemistry, 69, 869-880. [Google Scholar] [CrossRef] [PubMed]
[28] Toro, D.H., Bofill-Garcia, A. and Anzalota-Del Toro, M. (2024) Helicobacter pylori and Gastric Cancer: An Update in the Literature. Puerto Rico Health Sciences Journal, 43, 9-17.
[29] Li, C.Y., et al. (2022) Prevalence and Predictors of Helicobacter pylori Infection in Asymptomatic Individuals: A Hospital-Based Cross-Sectional Study in Shenzhen, China. Postgraduate Medicine, 134, 686-692.
https://pubmed.ncbi.nlm.nih.gov/35653281/
[30] Farah, R., Hanna, T. and Levin, G. (2024) Is There a Link between Atrial Fibrillation and Helicobacter pylori Infections? Minerva Gastroenterology, 70, 177-180. [Google Scholar] [CrossRef] [PubMed]
[31] Aslan, A., Karapinar, H.S., Kilicel, F., Boyacıoğlu, T., Pekin, C., Toprak, Ş.S., et al. (2023) Trace Element Levels in Serum and Gastric Mucosa in Patients with Helicobacter pylori Positive and Negative Gastritis. Journal of Trace Elements in Medicine and Biology, 75, Article ID: 127108. [Google Scholar] [CrossRef] [PubMed]
[32] Fan, D., Gong, Y., Sun, L., Zhang, Y. and Zhang, J. (2022) Comparative Transcriptome Analysis to Investigate the Mechanism of Anti-Helicobacter pylori Activity of Zinc. Microbial Pathogenesis, 168, Article ID: 105611. [Google Scholar] [CrossRef] [PubMed]
[33] Lakkireddy, D. (2020) Quantifying Risk Factors for Atrial Fibrillation: Retrospective Review of a Large Electronic Patient Database. Journal of Atrial Fibrillation, 13, Article 2365. [Google Scholar] [CrossRef] [PubMed]
[34] Li, Y., Liu, X., Li, Q., Zhou, P., Chen, Q., Jiang, B., et al. (2025) Association of Helicobacter pylori Infection with Lipid Metabolism and 10-Year Cardiovascular Risk in Diabetes Mellitus: A Cross-Sectional Study. PLOS ONE, 20, e0319688. [Google Scholar] [CrossRef] [PubMed]
[35] Costa, L.C.M.C., das Graças Carvalho, M., La Guárdia Custódio Pereira, A.C., Teixeira Neto, R.G., Andrade Figueiredo, L.C. and Barros-Pinheiro, M. (2024) Diagnostic Methods for Helicobacter pylori. Medical Principles and Practice, 33, 173-184. [Google Scholar] [CrossRef] [PubMed]
[36] Tang, J., Li, F., Liu, X., Wang, J., Xiong, X., Lu, X., et al. (2024) Detection of Helicobacter pylori Infection in Human Gastric Fluid through Surface-Enhanced Raman Spectroscopy Coupled with Machine Learning Algorithms. Laboratory Investigation, 104, Article ID: 100310. [Google Scholar] [CrossRef] [PubMed]
[37] Al Ofairi, B.A., Saeed, M.K., Al-Qubaty, M., Abdulkareem, A.M. and Al-Jahrani, M.A. (2024) Diagnostic Value of Igg Antibody and Stool Antigen Tests for Chronic Helicobacter pylori Infections in IBB Governorate, Yemen. Scientific Reports, 14, Article No. 7536. [Google Scholar] [CrossRef] [PubMed]
[38] Dong, Y., Zhu, J. and Pan, N. (2025) Recent Advances in Rapid Detection of Helicobacter pylori by Lateral Flow Assay. Archives of Microbiology, 207, Article No. 35. [Google Scholar] [CrossRef] [PubMed]